Reactive Hypoglycemia on GLP-1: Shaky After Eating
Why you feel shaky, dizzy, or weak 1-3 hours after eating on GLP-1 medication. Understand reactive hypoglycemia triggers, prevention, and when to seek medical help.
More on Blood Sugar & Diabetes
Medical Disclaimer
This article is for educational purposes only and does not replace professional medical advice. If you experience recurrent or severe post-meal symptoms, consult your healthcare provider. Do not adjust your GLP-1 dose without medical guidance.
What Is Reactive Hypoglycemia?
Reactive hypoglycemia, also called postprandial hypoglycemia, occurs when blood sugar drops below normal levels 1-3 hours after eating. Unlike fasting hypoglycemia (which occurs when you have not eaten), reactive hypoglycemia is triggered by eating itself, specifically by an exaggerated insulin response to a meal.
In a normal digestive process, eating carbohydrates causes blood sugar to rise, which signals the pancreas to release insulin. Insulin moves glucose from the bloodstream into cells for energy. In reactive hypoglycemia, the pancreas releases too much insulin relative to the glucose load, driving blood sugar below the starting point. The result is a "crash" that typically occurs 90 minutes to 3 hours after eating.
For people taking GLP-1 medications like semaglutide or tirzepatide, this pattern can be amplified. GLP-1 receptor agonists work by enhancing glucose-dependent insulin secretion, meaning they amplify your pancreas's insulin response when blood sugar is elevated. After a carbohydrate-rich meal, this enhanced response can sometimes overshoot, causing blood sugar to drop more sharply than it would without medication.
How GLP-1 Medications Contribute to Post-Meal Crashes
Three mechanisms explain why reactive hypoglycemia can occur or worsen on GLP-1 therapy:
Enhanced Insulin Secretion
GLP-1 agonists increase the amount of insulin your pancreas releases in response to rising blood sugar. While this is glucose-dependent (insulin release tapers as glucose normalizes), the initial insulin surge after a carb-heavy meal can be substantially larger than without medication. If the carbohydrate load does not match the insulin response, blood sugar drops below the comfortable range. This is particularly pronounced with high-glycemic foods that cause a rapid glucose spike followed by a rapid decline.
Delayed Gastric Emptying Creates Mismatched Timing
GLP-1 medications slow stomach emptying by 30-50%. This means food enters the small intestine and gets absorbed more gradually. However, the insulin response can still be triggered by early signals from the gut. The result is a timing mismatch: insulin peaks while glucose is still being slowly absorbed, creating a window where insulin action exceeds glucose availability. This mismatch is particularly noticeable during the first few weeks of treatment as your body adjusts.
Glucagon Suppression Reduces the Safety Net
Normally, when blood sugar starts dropping after a meal, the pancreas releases glucagon to trigger the liver to release stored glucose. GLP-1 medications suppress glucagon secretion, reducing this counter-regulatory response. Without the full glucagon "backup system," your body is slower to correct post-meal dips, allowing blood sugar to drift lower before stabilizing. Understanding how GLP-1 mechanisms work helps explain this interaction.
Recognizing the Pattern: Timeline of a Post-Meal Crash
Understanding the typical timeline helps you distinguish reactive hypoglycemia from other side effects of GLP-1 medications such as nausea or food aversion.
0-30 Minutes After Eating
Blood sugar begins rising as carbohydrates are digested. You feel satisfied and energized. Insulin secretion begins but has not peaked yet. This phase typically feels normal.
30-90 Minutes After Eating
Blood sugar peaks and insulin reaches its maximum effect. On GLP-1, the insulin surge may be stronger than without medication. Blood sugar begins its descent. If the meal was carb-heavy, this descent can be steep.
90 Minutes - 3 Hours After Eating
This is when reactive hypoglycemia strikes. Insulin is still active but glucose from the meal is largely absorbed. Symptoms appear: shakiness, sweating, rapid heartbeat, difficulty concentrating, irritability, or sudden overwhelming fatigue. Some people describe feeling "weak" or "hollow."
3-4 Hours After Eating
Counter-regulatory hormones (glucagon, cortisol, adrenaline) gradually kick in, and blood sugar begins recovering. Symptoms resolve, though you may feel fatigued for another 30-60 minutes. Eating a small balanced snack accelerates this recovery.
Dietary Strategies to Prevent Post-Meal Crashes
The most effective way to prevent reactive hypoglycemia on GLP-1 is to modify what and how you eat. These strategies reduce the insulin spike that triggers the crash.
Meal Composition Rules
- Always pair carbs with protein (20g+ per meal)
- Include healthy fats (avocado, olive oil, nuts)
- Choose complex carbs over simple sugars
- Add fiber-rich vegetables to every meal
- Limit total carbs to 30-40g per meal initially
Eating Order Strategy
- Eat vegetables and fiber first
- Follow with protein and fats
- Eat carbohydrates last
- This reduces glucose spike by up to 40%
- A 2023 study confirmed this works with GLP-1s
When Reactive Hypoglycemia Requires Medical Attention
While most cases of reactive hypoglycemia on GLP-1 are manageable with dietary adjustments, certain red flags warrant medical evaluation:
- Post-meal blood sugar consistently below 54 mg/dL despite dietary changes
- Loss of consciousness or near-fainting after meals
- Episodes occurring with every meal regardless of composition
- Symptoms that are worsening over time rather than improving
- New-onset symptoms in someone who has been stable on GLP-1 for months
Your provider may order a mixed-meal tolerance test, adjust your GLP-1 dose, or evaluate for other conditions that can cause reactive hypoglycemia, including insulinoma (very rare) or dumping syndrome. Visit our treatments page to discuss your options with our medical team.
Frequently Asked Questions
Why do I feel shaky 2 hours after eating on semaglutide?
This is likely reactive hypoglycemia, where your body overproduces insulin in response to a meal, causing blood sugar to drop below normal 1-3 hours later. GLP-1 medications enhance insulin secretion after meals, which can exaggerate this response, particularly after high-carbohydrate meals. The combination of enhanced insulin release and delayed gastric emptying can create an exaggerated blood sugar swing.
Is reactive hypoglycemia on GLP-1 dangerous?
For most non-diabetic patients, reactive hypoglycemia on GLP-1 is uncomfortable but not dangerous. Blood sugar typically drops to the 55-70 mg/dL range and recovers on its own. However, if you experience frequent episodes, blood sugar below 54 mg/dL, or symptoms like confusion or fainting, contact your healthcare provider for evaluation and possible dose adjustment.
What foods prevent reactive hypoglycemia on GLP-1?
Meals combining protein (at least 20g), healthy fats, and complex carbohydrates produce the most stable post-meal blood sugar. Avoid meals that are predominantly simple carbohydrates (white bread, pasta, sugary drinks). Starting your meal with protein or vegetables before eating carbohydrates can also help moderate the insulin response.
Should I stop taking GLP-1 if I keep getting shaky after meals?
Do not stop your medication without consulting your provider. Recurrent reactive hypoglycemia may be managed through dietary changes, meal timing adjustments, or dose modification. Your provider can evaluate whether a lower dose or different medication is appropriate. Most patients find that symptoms improve with dietary adjustments alone.
Expert Blood Sugar Management on GLP-1
Our providers help you optimize meals, adjust doses, and prevent post-meal crashes for comfortable GLP-1 therapy.
Schedule a ConsultationSources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).